Literature DB >> 7492859

Quality control of DXA instruments in multicenter trials.

K G Faulkner1, M R McClung.   

Abstract

Dual-energy X-ray absorptiometry (DXA) has become the measurement of choice for multicenter trials with bone density endpoints. When performing DXA measurements with several different systems, it is important to implement a quality assurance program to guarantee that any observed density changes are real and not due to machine and/or operator variability. In this study, we present a series of procedures based on phantom measurements designed to monitor DXA instrument stability. Techniques for longitudinal evaluation of machine performance and cross-calibration of instruments are described. These procedures are then demonstrated using quality assurance data collected from a number of different DXA scanners. Together these methods provide a defined approach to instrument quality control. Though based primarily on the use of spinal phantoms, these procedures can be generalized for use in any multicenter DXA study.

Mesh:

Year:  1995        PMID: 7492859     DOI: 10.1007/bf01774010

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  10 in total

1.  Assessment of spinal and femoral bone density by dual X-ray absorptiometry: comparison of lunar and hologic instruments.

Authors:  N A Pocock; P N Sambrook; T Nguyen; P Kelly; J Freund; J A Eisman
Journal:  J Bone Miner Res       Date:  1992-09       Impact factor: 6.741

2.  A phantom for standardization and quality control in spinal bone mineral measurements by QCT and DXA: design considerations and specifications.

Authors:  W A Kalender
Journal:  Med Phys       Date:  1992 May-Jun       Impact factor: 4.071

3.  Bone mass measurement by DXA: influence of analysis procedures and interunit variation.

Authors:  C Trevisan; G G Gandolini; P Sibilla; M Penotti; M P Caraceni; S Ortolani
Journal:  J Bone Miner Res       Date:  1992-12       Impact factor: 6.741

4.  Longitudinal precision of dual-energy x-ray absorptiometry in a multicenter study. The Nafarelin/Bone Study Group.

Authors:  E S Orwoll; S K Oviatt
Journal:  J Bone Miner Res       Date:  1991-02       Impact factor: 6.741

5.  A comparison of two dual-energy X-ray absorptiometry systems for spinal bone mineral measurement.

Authors:  K C Lai; M M Goodsitt; R Murano; C H Chesnut
Journal:  Calcif Tissue Int       Date:  1992-03       Impact factor: 4.333

6.  A multi-rule Shewhart chart for quality control in clinical chemistry.

Authors:  J O Westgard; P L Barry; M R Hunt; T Groth
Journal:  Clin Chem       Date:  1981-03       Impact factor: 8.327

7.  Quality assurance for bone densitometry research studies: concept and impact.

Authors:  C C Glüer; K G Faulkner; M J Estilo; K Engelke; J Rosin; H K Genant
Journal:  Osteoporos Int       Date:  1993-09       Impact factor: 4.507

8.  Precision of dual-energy x-ray absorptiometry: development of quality control rules and their application in longitudinal studies.

Authors:  E S Orwoll; S K Oviatt; J A Biddle
Journal:  J Bone Miner Res       Date:  1993-06       Impact factor: 6.741

9.  Quality control of bone densitometry in a national health survey (NHANES III) using three mobile examination centers.

Authors:  H W Wahner; A Looker; W L Dunn; L C Walters; M F Hauser; C Novak
Journal:  J Bone Miner Res       Date:  1994-06       Impact factor: 6.741

10.  Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results.

Authors:  H K Genant; S Grampp; C C Glüer; K G Faulkner; M Jergas; K Engelke; S Hagiwara; C Van Kuijk
Journal:  J Bone Miner Res       Date:  1994-10       Impact factor: 6.741

  10 in total
  13 in total

1.  Bone mineral density measures in longitudinal studies: the choice of phantom is crucial for quality assessment. The Tromsø study, a population-based study.

Authors:  Nina Emaus; G K R Berntsen; R Joakimsen; V Fønnebø
Journal:  Osteoporos Int       Date:  2005-05-11       Impact factor: 4.507

2.  Minimum sample size requirements for bone density precision assessment produce inconsistency in clinical monitoring.

Authors:  W D Leslie; A Moayyeri
Journal:  Osteoporos Int       Date:  2006-08-10       Impact factor: 4.507

3.  Guidelines for the clinical utilization of bone mass measurement in the adult population. Society for Clinical Densitometry.

Authors:  P D Miller; S L Bonnick; C Rosen
Journal:  Calcif Tissue Int       Date:  1995-10       Impact factor: 4.333

4.  Long-term quality control of DXA: a comparison of Shewhart rules and Cusum charts.

Authors:  D Pearson; S A Cawte
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

5.  Evaluation of the European Spine Phantom in a multi-centre clinical trial.

Authors:  B Lees; S W Garland; C Walton; J C Stevenson
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

6.  DXA longitudinal quality control: a comparison of inbuilt quality assurance, visual inspection, multi-rule Shewhart charts and Cusum analysis.

Authors:  S W Garland; B Lees; J C Stevenson
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

7.  Effectiveness of alendronate and etidronate in the treatment of osteoporosis in men: a prospective observational study.

Authors:  W P Olszynski; K S Davison; G Ioannidis; J P Brown; D A Hanley; R G Josse; T M Murray; A Papaioannou; R J Sebaldt; A M Tenenhouse; A Petrie; C H Goldsmith; J D Adachi
Journal:  Osteoporos Int       Date:  2005-07-05       Impact factor: 4.507

Review 8.  2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.

Authors:  Jacques P Brown; Robert G Josse
Journal:  CMAJ       Date:  2002-11-12       Impact factor: 8.262

9.  Differences in precision in bone mineral density measured by SXA and DXA: the NOREPOS study.

Authors:  Lisa Forsén; Gro K Rosvold Berntsen; Haakon E Meyer; Grethe S Tell; Vinjar Fønnebø
Journal:  Eur J Epidemiol       Date:  2008-07-02       Impact factor: 8.082

10.  The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years.

Authors:  Mishaela R Rubin; John P Bilezikian; Donald J McMahon; Thomas Jacobs; Elizabeth Shane; Ethel Siris; Julia Udesky; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2008-06-10       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.